Koyfin Home > Directory > Health Care > Amicus Therapeutics > Long-Term Debt / Capital

Amicus Therapeutics Long-Term Debt / Capital Chart (FOLD)

Amicus Therapeutics annual/quarterly Long-Term Debt / Capital from 2006 to 2018.
  • Amicus Therapeutics Long-Term Debt / Capital for the quarter ending December 12, 2018 was $48m a 49.95% increase of 24m year over year
  • Amicus Therapeutics Long-Term Debt / Capital for the last 12 months ending December 12, 2018 was $48m a 49.95% increase of 24m year over year
  • Amicus Therapeutics Annual Long-Term Debt / Capital for 2018 was $48m a 34.41% increase of 17m from 2017
  • Amicus Therapeutics Annual Long-Term Debt / Capital for 2017 was $32m a 5.52% increase of 2m from 2016
  • Amicus Therapeutics Annual Long-Term Debt / Capital for 2016 was $30m a 64.39% increase of 19m from 2015
Other Ratios Metrics:
  • Amicus Therapeutics Total Debt / Capital for the quarter ending September 09, 2018 was $44m a 27.22% increase of 12m year over year
  • Amicus Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $39m a -4.44% decrease of -2m year over year
  • Amicus Therapeutics Total Debt / Equity for the quarter ending September 09, 2018 was $78m a 39.91% increase of 31m year over year
View Chart On Koyfin

Quarterly FOLD Long-Term Debt / Capital Data

12/2018$48m
09/2018$44m
06/2018$23m
03/2018$24m
12/2017$32m
09/2017$28m
06/2017$37m
03/2017$34m
12/2016$30m
09/2016$16m

Annual FOLD Long-Term Debt / Capital Data

2018$48m
2017$32m
2016$30m
2015$11m
2014$8m
2013$24m
2012$0m
2010$2m
2009$3m
2008$0m